AvantorAVTR
AVTR
0
Funds holding %
of 6,823 funds
0
Analysts bullish %
of 4 analysts
Fund manager confidence
Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)
30% more funds holding in top 10
Funds holding in top 10: 10 [Q2] → 13 (+3) [Q3]
26% more capital invested
Capital invested by funds: $13.9B [Q2] → $17.5B (+$3.65B) [Q3]
20% more repeat investments, than reductions
Existing positions increased: 201 | Existing positions reduced: 168
11% more first-time investments, than exits
New positions opened: 80 | Existing positions closed: 72
3.42% more ownership
Funds ownership: 96.35% [Q2] → 99.76% (+3.42%) [Q3]
0% more funds holding
Funds holding: 500 [Q2] → 502 (+2) [Q3]
68% less call options, than puts
Call options by funds: $78.2M | Put options by funds: $248M
Research analyst outlook
4 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$25
13%
upside
Avg. target
$26
18%
upside
High target
$28
27%
upside
4 analyst ratings
3 positive
75%
1 neutral
25%
0 negative
0%
UBS Dan Leonard 29% 1-year accuracy 2 / 7 met price target | 13%upside $25 | Neutral Downgraded | 17 Jan 2025 |
Wells Fargo Brandon Couillard 44% 1-year accuracy 8 / 18 met price target | 27%upside $28 | Overweight Maintained | 28 Oct 2024 |
Baird Catherine Schulte 33% 1-year accuracy 7 / 21 met price target | 18%upside $26 | Outperform Maintained | 28 Oct 2024 |
Barclays Luke Sergott 23% 1-year accuracy 11 / 48 met price target | 13%upside $25 | Overweight Maintained | 25 Oct 2024 |
Financial journalist opinion
Based on 4 articles about AVTR published over the past 30 days
Positive
Zacks Investment Research
1 week ago
MD vs. AVTR: Which Stock Is the Better Value Option?
Investors with an interest in Medical Services stocks have likely encountered both Pediatrix Medical Group (MD) and Avantor, Inc. (AVTR). But which of these two stocks is more attractive to value investors?
Neutral
PRNewsWire
1 week ago
Avantor® to Report Fourth Quarter and Full Year 2024 Earnings on Friday, February 7, 2025
RADNOR, Pa. , Jan. 10, 2025 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, announced that it will release its fourth quarter and full year 2024 financial results before the market opens on Friday, February 7, and will hold a conference call to discuss the results on the same day at 8:00 a.m.
Neutral
PRNewsWire
2 weeks ago
Avantor® to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
RADNOR, Pa. , Jan. 3, 2025 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, announced that Michael Stubblefield, President and CEO, will present at the 43rd Annual J.P.
Positive
Zacks Investment Research
3 weeks ago
MD vs. AVTR: Which Stock Should Value Investors Buy Now?
Investors with an interest in Medical Services stocks have likely encountered both Pediatrix Medical Group (MD) and Avantor, Inc. (AVTR). But which of these two companies is the best option for those looking for undervalued stocks?
Positive
Seeking Alpha
1 month ago
Avantor: Durable FCF Generator Trading For Cheap
Avantor's robust business model yields stable cash flows and generates sticky customers. Avantor's leadership in the biopharma industry and shifting revenue mix can produce considerable margin expansion. Significant FCF generation can improve the company's capital structure and return value to shareholders.
Positive
Zacks Investment Research
1 month ago
MD or AVTR: Which Is the Better Value Stock Right Now?
Investors with an interest in Medical Services stocks have likely encountered both Pediatrix Medical Group (MD) and Avantor, Inc. (AVTR). But which of these two companies is the best option for those looking for undervalued stocks?
Neutral
PRNewsWire
2 months ago
Avantor® to Participate in the 7th Annual Evercore ISI HealthCONx Conference
RADNOR, Pa. , Nov. 20, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, announced that President and CEO, Michael Stubblefield, will be participating in a fireside chat at the Evercore ISI HealthCONx Conference in Coral Gables, Florida on Tuesday, December 3, at 9:10 a.m.
Neutral
Business Wire
2 months ago
Avantor to Distribute Quantum-Si's Next-Generation Protein Sequencing™ Technology
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, has announced a distribution agreement with Avantor® (NYSE: AVTR), a global leader in mission-critical products and services for the life sciences and advanced technology industries. Through this collaboration, Avantor will distribute Quantum-Si's Next-Generation Protein Sequencing (NGPS) portfolio, providing researchers across all market segments in t.
Neutral
PRNewsWire
2 months ago
Avantor® Opens New Bridgewater Innovation Center Focused on Solving Life Science's Biggest Challenges
RADNOR, Pa. , Nov. 14, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, today announced the opening of its new flagship Bridgewater Innovation Center.
Neutral
PRNewsWire
2 months ago
Avantor® Appoints Dame Louise Makin, DBE, Ph.D., to its Board of Directors
RADNOR, Pa. , Nov. 6, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, announced that the Avantor Board of Directors has appointed Dame Louise Makin, DBE, Ph.D.
Charts implemented using Lightweight Charts™